health-tech1.67 min read
"Oura Introduces Early Health Change Detection and User Testing Features"
1 year ago•Source: The Verge
Health Tech News
The latest health tech stories, summarized by AI
Featured Health Tech Stories
View original source
3.335 min•1 year ago
"AI-Enhanced Sepsis Diagnosis: Advancements in Early Detection and Precision Medicine"
The FDA has authorized Prenosis' AI-powered diagnostic tool, Sepsis ImmunoScore, as the first AI tool capable of diagnosing sepsis, a life-threatening condition. The tool uses 22 parameters to assess a patient's risk of sepsis and is integrated into electronic health records for easy access by clinicians. Prenosis worked with the FDA for 18 months to demonstrate the tool's safety and efficacy and plans to conduct additional studies to demonstrate its accuracy and impact on clinical decision-making.
More Top Stories
2
3
More Health Tech Stories
"Emerging AI Technologies and Epic's Innovations at HIMSS24: A Recap"
Originally Published 1 year ago — by Forbes
Epic Systems, a $4.6 billion health records giant, is developing a suite of 60 generative AI tools, including a prototype coding assistant powered by GPT-4, to streamline medical coding processes in hospitals. While the AI tool can suggest codes, it still requires human oversight and calibration due to potential inaccuracies. Epic aims to alleviate the burden on clinicians and address staffing shortages in healthcare through generative AI applications, but human touch remains crucial for complex cases. The company's incumbent advantage and partnerships with Microsoft and startup Abridge position it as a key player in the evolving landscape of AI in healthcare.
Eli Lilly Teams Up with Amazon Pharmacy for Prescription Drug Delivery
Originally Published 1 year ago — by Endpoints News
Eli Lilly has partnered with Amazon Pharmacy to deliver its obesity, diabetes, and migraine medications directly to patients through Lilly's telehealth platform, marking the first direct collaboration between Amazon's pharmacy business and a drugmaker. This new relationship could disrupt traditional medication prescription and dispensing processes, potentially reshaping the pharmaceutical and retail pharmacy industries while creating significant opportunities for Amazon Pharmacy.
"Revolutionizing Healthcare: The Impact of Apple Vision Pro on App Development"
Originally Published 1 year ago — by Apple
Apple Vision Pro is unlocking new opportunities for health app developers, allowing for the creation of breakthrough health and wellness apps that take advantage of spatial experiences in clinical settings and at home. The technology is being used in areas such as surgical planning, medical imaging, behavioral health, and more, with apps like myMako, CyranoHealth, and Cinematic Reality offering immersive and transformative experiences for healthcare professionals and patients. The unique capabilities of visionOS are enabling developers to create apps that were not previously possible, revolutionizing the healthcare industry and improving patient outcomes.
"Salesforce Introduces Advanced AI Tools for Developers and Doctors"
Originally Published 1 year ago — by CNBC
Salesforce has unveiled new AI tools for healthcare workers, including Einstein Copilot: Health Actions and Assessment Generation, aimed at reducing administrative burdens. These tools, built on the Einstein 1 Platform, enable doctors to streamline tasks such as appointment booking and patient information summarization using conversational AI. The company aims to address the burnout caused by labor-intensive administrative tasks and data fragmentation in healthcare systems. The tools are expected to comply with HIPAA regulations and will be available for use later this year.
"Dexcom's Stelo: First FDA-Cleared OTC Continuous Glucose Monitor"
Originally Published 1 year ago — by CNBC
Dexcom has received FDA clearance for its over-the-counter continuous glucose monitor, Stelo, designed for Type 2 diabetes patients who do not use insulin. This marks the first glucose biosensor not requiring a prescription, making it accessible to those without insurance coverage for CGMs. The device, to be available online this summer, offers real-time glucose tracking and lasts up to 15 days. Dexcom aims to provide a simpler experience tailored for Type 2 patients and plans to eventually secure insurance coverage for Stelo.
"FDA Clears Dexcom's Stelo as First Over-the-Counter Continuous Glucose Monitor"
Originally Published 1 year ago — by FDA.gov
The FDA has approved the first over-the-counter continuous glucose monitor, the Dexcom Stelo Glucose Biosensor System, designed for individuals 18 years and older who do not use insulin. This integrated CGM allows users to monitor and analyze glucose levels using a wearable sensor and a smartphone app, providing valuable information about their health without the involvement of a healthcare provider. However, it is not intended for individuals with problematic hypoglycemia. This approval aligns with the FDA's goal of advancing health equity by expanding access to valuable health information for all patients.
"Abridge Secures $150M Series C for Advancing AI Clinical Documentation Tools"
Originally Published 1 year ago — by Forbes
Abridge, a startup specializing in AI medical scribing, has raised $150 million in a Series C funding round led by Lightspeed and Redpoint Ventures, bringing its post-money valuation to $850 million. The company aims to enhance its AI technology to create more useful medical notes, improve clinical documentation, and compete with industry giants like Nuance in the electronic health records space. The funding will support Abridge's expansion into more hospitals and further research and development efforts.
"AI-Enhanced Colonoscopy Boosts Polyp Detection by 40%: Study"
Originally Published 1 year ago — by DutchNews.nl
Researchers at Radboud teaching hospital in the Netherlands are using AI to detect polyps in the colon, leading to a 40% increase in detection compared to the naked eye. The AI-assisted colonoscopy method did not result in more time or false positives. The next step is to determine if the computer can assess the danger level of a polyp based on its visual characteristics and size, potentially reducing the need for unnecessary analysis and lowering the risk of complications and costs.
"Samsung Galaxy Watch Receives FDA Clearance for Sleep Apnea Detection Feature"
Originally Published 1 year ago — by ZDNet
The Samsung Galaxy Watch has received FDA clearance for a sleep apnea detection feature, set to be available in the third quarter of this year. The feature will track signs of moderate to severe obstructive sleep apnea by monitoring blood oxygen levels and notifying users through the Samsung Health Monitor app. While the company warns against using it as a replacement for traditional diagnosis and treatment, this new feature aims to help users proactively spot symptoms of sleep apnea and reduce health-related complications.
"Samsung Galaxy Watch Receives FDA Approval for Sleep Apnea Detection"
Originally Published 1 year ago — by GSMArena.com
Samsung has received FDA approval for a sleep apnea feature in the Samsung Health Monitor app, which will be available on compatible Galaxy Watches in the US, starting in the third quarter of this year. The feature will detect signs of moderate to severe obstructive sleep apnea over a two-night monitoring period, potentially helping more people identify and seek treatment for this common and chronic sleep condition.